US equities
|
MU
$910.10
▲+0.57%
NVDA
$216.89
▼-0.09%
SPCX
$147.75
▼-0.14%
TSLA
$373.97
▲+1.61%
META
$691.00
▼-2.05%
SNDK
$1,382.37
▲+0.82%
INTC
$92.54
▲+0.55%
AMZN
$262.91
▲+0.18%
MU
$910.10
▲+0.57%
NVDA
$216.89
▼-0.09%
SPCX
$147.75
▼-0.14%
TSLA
$373.97
▲+1.61%
META
$691.00
▼-2.05%
SNDK
$1,382.37
▲+0.82%
INTC
$92.54
▲+0.55%
AMZN
$262.91
▲+0.18%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Dr/ Sunil Aggarwal
Recent news which mentions Dr/ Sunil Aggarwal
The Fate Of Psilocybin's Rescheduling Petition: DEA Retains Control As Federal Court Confirms Case Jurisdiction
December 15, 2023
Tags
Federal Schedule I
Regulations
Drug Enforcement Administration
From
Benzinga
DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court
October 30, 2023
Tickers
DEA
Tags
DEA
Dr/ Sunil Aggarwal
Psychedelics
From
Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
Tickers
CSA
DEA
Tags
Benzinga
psilocybin therapy
News
From
Benzinga